BB Biotech - Picking growth at good value
According to BB Biotech’s (BION’s) investment team, the biotech industry remains in a very good position. Following a sell-off in the last two...
295 Views
BB Biotech - Great valuation potential
According to BB Biotech’s (BION) investment team, the biotech industry has never looked in such a good position. Following a sell-off in the last...
672 Views
Video: BB Biotech - fund manager interview
Daniel Koller, lead fund manager of Switzerland-based BB Biotech, reflects on an extraordinary year for the world at large and the healthcare...
1.1k Views
BB Biotech - RNA focus provides a possible COVID-19 solution
BB Biotech (BION) recently updated the market on its views on the COVID-19 pandemic and how they are reflected in its portfolio (see video link...
198 Views
BB Biotech - High-conviction specialist with impressive record
BB Biotech (BION) is a long-established (since 1993), Switzerland-based global investor in the innovative area of biotechnology. It is...
107 Views